Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1100 µG brimonidine tartrate implant----[1] 90 💬
2200 µG brimonidine tartrate implant----[1] 90 💬
3400 µG brimonidine tartrate implant----[1] 90 💬
4Brimonidine tartrate[1] Brimonidine (Brimonidine tartrate)[2] Brimonidine tartrate (Brimonidine tartrate, BRIMONIDINE TARTRATE, BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION, 0.15%),
Brimonidine 💬 		[3] ADRA2A,
ADRA2B,
ADRA2C 💬 		[4] Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬[1] 13 💬
5Brimonidine tartrate posterior segment drug delivery system (brimo PS DDS) applicator system[1] Brimonidine (Brimonidine tartrate)[2] Brimonidine tartrate (Brimonidine tartrate, BRIMONIDINE TARTRATE, BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION, 0.15%),
Brimonidine 💬 		[3] ADRA2A,
ADRA2B,
ADRA2C 💬 		[4] Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬[1] 90 💬